Stay updated on Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.

Latest updates to the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag on the page updated from v3.6.4 to v3.6.5. This indicates a minor platform update applied to the page without changing study content or public-facing information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, reflecting a new release of the page template. This update does not modify the study details or other substantive content.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3. This denotes a small behind-the-scenes update to the page version; no study content was altered.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s revision label at the bottom updated from v3.6.0 to v3.6.2. This reflects a backend or template update of the page, not changes to the study information displayed.SummaryDifference0.1%

- Check70 days agoChange DetectedRecruitment status now shows 'No longer looking for participants' and new help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added to the page. The header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision note progressed from 'Revision: v3.5.5' to 'Revision: v3.6.0'.SummaryDifference0.5%

- Check77 days agoChange DetectedThe page's revision metadata updated from v3.5.4 to v3.5.5, signaling a platform update. This change does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.